The Development and Efficacy of a Recovery Group for People With Mental Illness

Recovery-oriented approach has been promoted in psychiatric rehabilitation in recent years. This approach emphasizes that people with mental illness can live a hopeful life even though the symptoms still exist. However, few recovery-oriented programs are available in Taiwan. This study aimed to develop of a recovery-oriented program for people with mental illness and investigate its feasibility.

Study Overview

• Status: Completed
• Conditions: Mental Illness
• Intervention / Treatment: Other: Recovery group

Detailed Description

The study participants with mental illness were from a community mental health center in the south of Taiwan. The recovery-oriented program was conducted by a group leader, a senior occupational therapist, with one supervisor and one observer. The program was designed based on Pathways to Recovery, a self-help book published by University of Kansas. Participants attended a 1-hour class per week. The teaching methods included didactic presentation, peer exchange, group discussion, and practice. The group leader, supervisor, and observer reviewed the content and participants' performance after each class and made content adjustments if needed.

• Study Type: Interventional
• Enrollment (Actual): 24
• Phase: Not Applicable

Contacts and Locations

Study Locations

• Taiwan
  • Tainan, Taiwan
    • National Cheng Kung University Hospital

Participation Criteria

Eligibility Criteria

• Ages Eligible for Study: 20 years and older (Adult, Older Adult)
• Accepts Healthy Volunteers: No
• Genders Eligible for Study: All

Description

Inclusion Criteria:

• diagnosis of mental illness

Exclusion Criteria:

-

Study Plan

How is the study designed?

Design Details

• Primary Purpose: Treatment
• Allocation: N/A
• Interventional Model: Single Group Assignment
• Masking: None (Open Label)

Number of Arms

1

Arms and Interventions

Participant Group / Arm	Intervention / Treatment
Other: Recovery group; The researchers designed a recovery group suited to Taiwanese with mental illness, according to content of the PTR (Ridgway et al., 2002) and recovery-related literature (Davidson et al., 2005; Ridgway, 2001). The group gathered for a one-hour session once a week for 18 weeks.	Other: Recovery group; The researchers designed a recovery group suited to Taiwanese with mental illness, according to content of the PTR (Ridgway et al., 2002) and recovery-related literature (Davidson et al., 2005; Ridgway, 2001)

What is the study measuring?

Primary Outcome Measures

Outcome Measure	Measure Description	Time Frame
Stages of Recovery Scale：Change from Baseline at 10 weeks and 18 weeks	The scale consists of 45 items, with six subscales: the sense of hope, disability management/taking responsibility, regaining autonomy, social functioning/role performance, overall well-being, and willingness to help. It has good internal consistency and proper construct validity. The SRS utilizes a 4-point rating scale: never (0), seldom (1), sometimes (2), and often (3). Higher scores indicate better recovery. The developers also provide the cutoff scores for four recovery stages: Stage 1 (overwhelmed by the disability), 0-57; Stage 2 (struggling with disability), 58-90; Stage 3 (living with disability), 91-119; and Stage 4 (living beyond disability), 120-135.	baseline, 10 weeks, 18 weeks

Collaborators and Investigators

• Sponsor: National Cheng-Kung University Hospital
• Investigators: Study Chair: Chang Yen-Ching, National Cheng-Kung University Hospital

Study record dates

Study Major Dates

• Study Start (Actual): December 14, 2017
• Primary Completion (Actual): July 12, 2018
• Study Completion (Actual): July 12, 2018

Study Registration Dates

• First Submitted: July 16, 2019
• First Submitted That Met QC Criteria: August 29, 2019
• First Posted (Actual): September 3, 2019

Study Record Updates

• Last Update Posted (Actual): September 3, 2019
• Last Update Submitted That Met QC Criteria: August 29, 2019
• Last Verified: July 1, 2019

More Information

Terms related to this study

• Additional Relevant MeSH Terms: Mental Disorders
• Other Study ID Numbers: A-ER-106-245

Plan for Individual participant data (IPD)

• Plan to Share Individual Participant Data (IPD)?: NO

Drug and device information, study documents

• Studies a U.S. FDA-regulated drug product: No
• Studies a U.S. FDA-regulated device product: No